about
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyAnthropological Measurement of Lower Limb and Foot Bones Using Multi-Detector Computed TomographyImaging biomarker roadmap for cancer studiesA minimum data set approach to post-mortem computed tomography reporting for anthropological biological profiling.A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer.Intravenous ω-3 Fatty Acids Plus Gemcitabine.Diagnostic accuracy of post-mortem CT with targeted coronary angiography versus autopsy for coroner-requested post-mortem investigations: a prospective, masked, comparison studyThe effect on toxicology, biochemistry and immunology investigations by the use of targeted post-mortem computed tomography angiography.The scoliosis of Richard III, last Plantagenet King of England: diagnosis and clinical significance.Perimortem trauma in King Richard III: a skeletal analysis.Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.The role of imaging in the clinical development of antiangiogenic agents.A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging.Spontaneous regression of metastatic renal cell carcinoma: case reportComputed tomography of projectile injuries.Post-mortem computed tomography coaxial cutting needle biopsy to facilitate the detection of bacterioplankton using PCR probes as a diagnostic indicator for drowning.Intra-arterial brachytherapy of hepatic malignancies: watch the flow.Post-mortem computed tomography angiography: past, present and future.Opportunities and pitfalls of cancer imaging in clinical trials.Targeted cardiac post-mortem computed tomography angiography: a pictorial review.Post-mortem computed tomography and 3D imaging: anthropological applications for juvenile remains.Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions.The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer.Mobile computed tomography for mass fatality investigations.Postmortem computed tomography (PMCT) and disaster victim identification.Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer.Adult post-mortem imaging in traumatic and cardiorespiratory death and its relation to clinical radiological imaging.Postmortem computed tomography age assessment of juvenile dentition: comparison against traditional OPT assessment.Fimag: the United Kingdom disaster victim/forensic identification imaging system.The role of mobile computed tomography in mass fatality incidents.A phase 2 study of vatalanib in metastatic melanoma patients.Anthropological measurement of the juvenile clavicle using multi-detector computed tomography--affirming reliability.The use of dilute Calogen as a fat density oral contrast medium in upper abdominal computed tomography, compared with the use of water and positive oral contrast media.Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer aPhase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.Terminology used in publications for post-mortem cross-sectional imaging.Routine use of positive oral contrast material is not required for oncology patients undergoing follow-up multidetector CT.Pump injector system applied to targeted post-mortem coronary artery angiography.
P50
Q28655985-90512C80-4061-4E9F-BA7C-4E8F229F0BDCQ29544574-6C1367D4-860C-45BA-AD93-7EFBA70E5FF6Q30242020-34F59F01-AB99-4900-B7D4-FF7D6039863DQ30837100-94052322-8F1D-4DC2-B0A7-A729BC3C7167Q33385896-4BE1A99B-0AD5-4D03-BC01-7B49EF631BD2Q33424793-0BCBFCA9-D08D-4D42-85A9-0D136786FE8DQ33895531-1B6E3052-ACB1-4579-A427-1DFC8FB877E7Q34281966-14AC8394-7A38-496B-8A94-A8E3E779C652Q34422218-78B0030C-DCFE-40D5-BA7E-58CC0DD77FE7Q34439585-e3989363-4819-fa55-530b-34e6df147738Q35152536-A395315C-11D2-4ED5-A9E2-134304E51D76Q35358778-31DBE002-94D1-4BE8-AEF4-C3032FCEDA1DQ35876385-A753B826-B147-4155-8CA5-14F0769966ACQ35913192-B8419120-8705-4FD3-B7DA-A28773CF94E4Q36614213-E1CE603E-D6B6-4EE2-8DA8-03B110E97D5AQ36945171-4E7F3F96-CB77-4C28-805D-DBC23B40692CQ37261860-96CDC204-B43D-4D92-AB84-45382C1B5115Q37547398-91FFDFED-7FCC-468F-9B6E-2993C61154EFQ37798154-F7AF32ED-B84B-498D-BB15-282F30866553Q37820420-79143810-F6CF-4C63-BEAA-8D4BB30D88A8Q37869334-086F2659-47E1-4001-B357-704B72BC40FCQ37910810-61DACB2F-C7E1-45D2-82CE-F29DD9F05C60Q38009723-B9602929-BC32-421C-89B5-745BE9DA4449Q38112750-EB3C7DD4-7670-4251-BCCA-9B3A2C368BADQ38114076-3CDB6673-3DB7-4025-A797-B010EA64F89CQ38418979-17668A3E-672A-4D51-A87C-3D70C71A7768Q38537065-1CA906A2-DDC4-44DE-90D2-051A9311863DQ39198025-5E884C7C-FDDF-44A9-B94B-D15511A1BF59Q41012633-A2E0B56D-B37B-4E1B-B803-B43734CFEC63Q41964842-21CEC7B8-7F4A-4597-A8D2-EDECD8AE6A1EQ41993764-318EDFF0-CCE9-4DF5-AFA1-34C3F21D4B02Q42007849-58120114-C190-4B25-A28E-6932A826D344Q42923862-F51E8FE6-AD1D-4FD1-B2BA-DA19A5A5EC62Q43425369-B304A2E5-F50F-4877-B57B-C849554EC427Q43684398-7625FC42-8E9B-467C-BC69-3A19B077DAE5Q44601128-47322865-E401-4DFB-A6A7-5678910764C5Q45122000-045C3FAD-629A-4759-AE0B-229BA1451BF6Q45401386-9B6677AC-8CC6-4EED-B0EA-14F3A547951CQ46192774-68A69272-AE88-469D-BB2A-3E9B8E47CC62Q46205488-AA9BFAD9-8BE8-42FF-8558-848604421B00
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Morgan
@ast
Bruno Morgan
@en
Bruno Morgan
@es
Bruno Morgan
@nl
Bruno Morgan
@sl
type
label
Bruno Morgan
@ast
Bruno Morgan
@en
Bruno Morgan
@es
Bruno Morgan
@nl
Bruno Morgan
@sl
prefLabel
Bruno Morgan
@ast
Bruno Morgan
@en
Bruno Morgan
@es
Bruno Morgan
@nl
Bruno Morgan
@sl
P106
P1153
7402905542
P21
P31
P496
0000-0001-9708-675X